Large-scale testing (Phase 3)Study completedNCT00366249
What this trial is testing
Study Evaluating the Safety and Efficacy of a Once-daily Dose of Tigecycline vs Ertapenem in Diabetic Foot Infections (DFI) With a Substudy in Patients With Diabetic Foot Infections Complicated by Osteomyelitis.
Who this might be right for
Bacterial InfectionsDiabetic FootOsteomyelitis
Wyeth is now a wholly owned subsidiary of Pfizer 1,061